- Home
- FG vs KRYS Comparison
FG vs KRYS Comparison
Compare FG & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FG
- KRYS
- Stock Information
- Founded
- FG 1959
- KRYS 2015
- Country
- FG United States
- KRYS United States
- Employees
- FG N/A
- KRYS N/A
- Industry
- FG Life Insurance
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FG Finance
- KRYS Health Care
- Exchange
- FG Nasdaq
- KRYS Nasdaq
- Market Cap
- FG 4.3B
- KRYS 4.3B
- IPO Year
- FG N/A
- KRYS 2017
- Fundamental
- Price
- FG $31.97
- KRYS $153.87
- Analyst Decision
- FG Hold
- KRYS Strong Buy
- Analyst Count
- FG 3
- KRYS 11
- Target Price
- FG $43.33
- KRYS $204.27
- AVG Volume (30 Days)
- FG 161.2K
- KRYS 280.8K
- Earning Date
- FG 08-06-2025
- KRYS 08-04-2025
- Dividend Yield
- FG 2.76%
- KRYS N/A
- EPS Growth
- FG 91.46
- KRYS 109.01
- EPS
- FG 3.84
- KRYS 4.16
- Revenue
- FG $5,139,000,000.00
- KRYS $333,448,000.00
- Revenue This Year
- FG N/A
- KRYS $40.10
- Revenue Next Year
- FG $19.03
- KRYS $49.73
- P/E Ratio
- FG $8.32
- KRYS $37.04
- Revenue Growth
- FG N/A
- KRYS 247.53
- 52 Week Low
- FG $30.01
- KRYS $122.80
- 52 Week High
- FG $50.75
- KRYS $212.06
- Technical
- Relative Strength Index (RSI)
- FG 52.45
- KRYS 61.11
- Support Level
- FG $30.56
- KRYS $147.35
- Resistance Level
- FG $32.71
- KRYS $154.99
- Average True Range (ATR)
- FG 0.80
- KRYS 4.53
- MACD
- FG 0.10
- KRYS 0.14
- Stochastic Oscillator
- FG 72.73
- KRYS 70.61
About FG F&G Annuities & Life Inc.
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.